![]() |
|
|
1

*
TNO Nutrition and Food Research, 3700 AJ Zeist, the Netherlands and
Department of Pharmacology and Toxicology, Faculty of Medicine, University of Maastricht, 6200 MD, Maastricht, the Netherlands
1To whom correspondence should be addressed at TNO Nutrition and Food Research, Department of Nutritional Physiology, Utrechtseweg 48, P.O. Box 360, 3700 AJ Zeist, the Netherlands. E-mail: R.vandenBerg{at}voeding.tno.nl
| ABSTRACT |
|---|
|
|
|---|
-carotene, ß-carotene,
ß-cryptoxanthin and zeaxanthin and plasma total antioxidant capacity.
However, no effects were demonstrated on any marker of oxidative damage
to lipids (malondialdehyde F2-isoprostane) proteins
(carbonyls) and DNA (Comet assay) and (functional) markers of oxidative
stress (reduced/oxidized glutathione ratio,
glutathione-S-transferase
,
glutathione-S-transferase
and nuclear transcription
factor-
B). Apparently, these increased levels of antioxidants in
serum were not sufficiently high to show beneficial changes with the
selected biomarkers. Alternatively, oxidative stress in male smokers
with a relatively low fruit and vegetable intake might have been still
too low to demonstrate a beneficial effect of antioxidants.
KEY WORDS: oxidative stress humans antioxidants smokers fruit and vegetables
| INTRODUCTION |
|---|
|
|
|---|
Protection against cardiovascular disease by a high consumption of
fruits and vegetables has also been suggested (5
,6)
.
Additional evidence comes from preclinical studies, such as in vitro or
animal studies (7)
. However, such data are of limited
value because of difficulties in extrapolating to the human situation,
e.g., due to uncertainties with respect to bioavailability and tissue
distribution or, as in animal models, differences in metabolism and
metabolic rate (8)
.
The potential health benefits of fruits and vegetables have been
attributed to the effects of specific ingredients in fruits and
vegetables, such as vitamins, dietary fiber and a wide range of
bioactive compounds, such as flavonoids. Antioxidant activity is
considered to play an important role in the protective effects of
fruits and vegetables (9
10
11
12
13)
. This is in part based on
the increasing evidence that oxidative damage is involved in the
pathogenesis of atherosclerosis and in carcinogenesis
(14
,15)
.
The aim of the present study was to evaluate the sensitivity of
biomarkers of oxidative damage and (functional) biomarkers of oxidative
stress and the potential to demonstrate beneficial effects with these
biomarkers in a potential risk group with a relatively low
"habitual" vegetable and fruit consumption using "natural"
products. In this report, we describe the results of a cross-over
intervention study with antioxidants in a "natural" matrix and
other bioactive compounds from fruit and vegetables in a group of male
smokers with a relatively low habitual fruit and vegetable intake. We
used a vegetable burger
(VB)2
with commercially available lyophilized vegetables, containing the
equivalent of
500 g mixed "fresh" vegetables (tomatoes, carrots,
onions, broccoli and red sweet pepper) per daily portion and a fruit
drink (FD) prepared from fruit (orange, blueberry, apple, lemon and
lime) concentrate. The vegetables and fruits selected for preparation
of the test products were considered to be significant sources of
antioxidants associated with the beneficial health effects, as
suggested in observational epidemiological and experimental studies
(12
,16
17
18)
.
The effects of the VB/FD on the antioxidant status (vitamins C and E,
retinol, carotenoids), plasma trolox equivalent antioxidant capacity
(TEAC) and selected biomarkers of oxidative damage [malondialdehyde
(MDA), F2-isoprostane, protein carbonyls, DNA
damage (Comet assay)] and oxidative stress [reduced/oxidized
glutathione ratio (GSH/GSSG ratio),
glutathione-S-transferases (GST
, GST
)] were assessed.
Activity of the nuclear transcription factor-
B (NF-
B) was
determined in peripheral blood mononuclear cells (PBMC). This factor is
involved in carcinogenic and inflammatory processes and is under redox
control, i.e., activated under conditions of increased cellular
oxidative stress (19)
, and therefore is considered as an
early functional marker of oxidative stress.
| SUBJECTS AND METHODS |
|---|
|
|
|---|
The study was performed according to the guidelines for Good Clinical Practice of the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use at the Department of Nutritional Physiology of TNO Nutrition and Food Research, Zeist, the Netherlands. The protocol was approved by the local medical ethics committee.
Smoking, male (aged 1850 y) subjects were recruited from the pool of
volunteers of the institute. The protocol was carefully explained to
the volunteers, and their written informed consent was obtained.
Subjects were eligible if they fulfilled the following inclusion
criteria: i) apparently healthy as indicated by a general
medical questionnaire, physical examination and a "normal" clinical
chemical blood profile, ii) currently smoking
10
cigarettes/d for
1 y and no intention to stop during the study
period, iii) a body mass index [BMI; body weight
(kg)/height (m2)]
30, iv) low use
of vegetables, fruits and fruit drinks as assessed by a food frequency
questionnaire (subjects with the lowest quantified vegetable/fruit
intake were selected), v) moderate alcohol consumption of
28 U/wk (1 U = 10 g alcohol),
vi) regular (Dutch) food pattern and vii) no use
of vitamin and/or food supplements.
Twenty-four men entered the study. Two subjects withdrew during the first treatment period of the study due to dislike of the test products. One subject withdrew on d 1 and was replaced. Therefore, data for 21 subjects were available on d 1 and data for 22 subjects were available on d 22 and 57.
Study design
The study was designed as a randomized, free living, open placebo-controlled cross-over trial. The study consisted of two treatment periods of 3 wk with a 2-wk washout period between periods. Each subject received test products (VB/FD) and the respective control products [control burgers and control drinks (CB/CD)] in a randomized order. Subjects were instructed to maintain their usual diet and to use one portion of either test products or control products per day during 3 wk at a self-selected moment but not replacing a meal. Half of the subjects started with the test products for 3 wk and changed over after 2 wk washout to the control products; the other half of the subjects did the opposite. Each week, volunteers were supplied with fresh products and instructed to store the products in a refrigerator.
At d 1, 22 and 57, body weight was assessed with the subject wearing
indoor clothing, without shoes, wallet and keys. Systolic and diastolic
blood pressure and heart rate were measured oscillometrically in a
sitting position and in the right arm after a
5-min rest. Blood
samples were collected for analysis of various status, damage and
stress variables as described later.
Test products
A VB was prepared using commercially available lyophilized vegetables, provided by Keizer Waalwijk BV, the Netherlands (lyophilized by Kerry Ingredients BV, the Netherlands) and an FD prepared from fruit juice concentrates (SVZ International, Etten-Leur, the Netherlands).
The VB, of
100 g, contained the equivalent of
500 g mixed
"fresh" vegetables, consisted of 40 g mixed freeze-dried
vegetables (equivalent to
85 g broccoli, 47 g tomato, 84 g
carrot, 99 g red sweet pepper and 156 g onion), mixed with
39.5 g chicken meat, 5 g of palm oil carotenoids (in corn
oil; Quest International, Maarssen, the Netherlands) and a mix of
spices (Table 1
). The FD, of
330 mL, consisted of a mixture of tap waterdiluted
juice concentrates of orange (30%), blueberry (30%), apple (30%),
lemon (5%) and lime (5%).
|
100 g, that consisted of 70.5 g chicken meat, 11 g of corn oil and a mix of spices (similar as
in test product; Table 1
330 mL water and fructose (0.2 g/L). The CD had a similar energy
content as the FD. The ingredients of the VB and FD were selected for
their high antioxidant contents and mixed in a ratio to achieve
tasteful products. Blood samples
On d 1, 22 and 57, blood samples were collected from fasting
subjects, between 0800 and 0930 h. For analysis of vitamins A and
E, carotenoid profile, triglycerides, total cholesterol and HDL
cholesterol, blood was collected in tubes containing clot activator
(Vacutainer systems; Becton Dickinson, Leiden, the Netherlands) and
further prepared on ice under subdued light. Within 30 min, the tubes
were centrifuged (10 min at 2000 x g at 4°C). Serum
samples for analysis of vitamins A and E and carotenoid concentrations
were stored at <-70°C until analysis. Samples for analysis of
triglycerides and total and HDL cholesterol were stored at
<-18°C and analyzed within 2 mo. For analysis of
8-epi-prostaglandin F2
(F2-isoprostane), blood was collected in tubes
containing 38 g sodium citrate/L (Vacutainer systems). Directly
after collection, indomethacin (14 µmol/L) and BHT (20 µmol/L) were
added, and the tubes were centrifuged (10 min at 2000 x g at 4°C). Plasma was removed for analysis of
F2-isoprostane, placed on ice and stored at
<-70°C. For all other parameters, blood was collected in tubes
containing lithium heparin (Vacutainer systems; Becton Dickinson). For
analysis of vitamin C, directly after collection, 0.5 mL blood was
added to 2.0 mL metaphosphoric acid (50 g/L; J. T. Baker,
Deventer, the Netherlands) under continuous vortexing. This mixture was
placed on dry ice, stored at <-70°C and analyzed within 5 d.
For analysis of TEAC, MDA, protein carbonyls and GST-
, within 15
min, blood was centrifuged (10 min at 2000 x g at
4°C). Plasma samples were immediately placed on dry ice and stored at
<-70°C. For analysis of DNA breakage, NF-
B activity and GST-
,
immediately after blood collection, PBMC were isolated. Heparinized
blood was transferred into Leucosep tubes containing Ficoll Paque and
diluted with a balanced salt solution. Samples were centrifuged (30 min
at 800 x g and 4°C), and subsequently PBMC were
collected, washed twice and divided over the aliquots needed. Cell
concentrations were determined, and samples were directly used for
analysis of GST-
and for isolation of nuclear proteins (NF-
B) or
stored at <-70°C for analysis of DNA breakage. For analysis of
GSH/GSSG ratio, blood was placed on ice, centrifuged (5 min at 5000
x g) and immediately used for determination of
GSH/GSSG in erythrocytes. The resulting erythrocytes were washed, and 1
mL of 10 mmol HCl/L plus 6.5% 5-sulfosalicyl acid was added to 450
µL erythrocytes, mixed and put on ice for 10 min. Samples were
centrifuged (15 min at 2000 x g at 4°C), and the
supernatant was rapidly frozen on dry ice and stored at <-70°C.
Biochemical and chemical analyses
Characterization of products. All study products (VB/FD and CB/CD) were characterized by chemical analysis of macronutrient composition and antioxidant contents. Protein, carbohydrate and total fat concentrations were analyzed using standard methodology, and energy values were calculated based on the results of macronutrient composition.
The antioxidant content was established by analyses of vitamin C, total
vitamin E (only burgers) and carotenoid profile. For vitamin C
analyses, VB and CB were first extracted with trichloroacetic acid and
FD and CD were deproteinated with metaphosphoric acid, followed by
filtration, oxidation to dehydro-L-ascorbic acid and
condensation according to a method reported by Speek et al.
(20)
.
Total vitamin E and carotenoid concentrations were analyzed after
saponification with KOH followed by extraction with diisopropylether
and HPLC with fluorometric detection for vitamin E (21)
and spectrophotometric detection for carotenoids (22)
. The
results of the macronutrient composition (protein, carbohydrate and
fat), carotenoid profile (lutein, zeaxanthin, ß-cryptoxanthin,
lycopene,
-carotene and ß-carotene), vitamin E and vitamin C
concentrations of the burgers and drinks (except for vitamin E) are
summarized in Table 2
.
|
The in vitro antioxidant capacity was measured as the Trolox equivalent
antioxidant capacity (TEAC) as described by van den Berg et al.
(24)
. Briefly, VB and CB were extracted with 70%
methanol. Samples of VB/CB or FD/CD were added to an
2,2'-azinobis-(3-ethylbenzthiazoline-6-sulfonate) radical solution, and
the decrease in radical concentration was monitored
spectrophotometrically.
Blood lipid and antioxidant measurements.
Serum lipids and serum triglycerides were analyzed by enzymatic
hydrolysis with subsequent enzymatic determination of the liberated
glycerol by colorimetry (Boehringer, Mannheim, Germany). Total
cholesterol was analyzed by enzymatic conversion to a stable chromogen,
which can easily be detected with colorimetry (Boehringer). HDL
cholesterol was analyzed by precipitation with polyethylene glycol,
centrifugation and enzymatic detection by colorimetry (Boehringer), and
LDL cholesterol was calculated using the Friedewald formula
(25)
.
Total antioxidant capacity as measured by the TEAC was determined
according to the method described (24)
. Briefly, plasma
samples were deproteinized by adding an equal volume of 10%
trichloroacetic acid. After centrifugation, the supernatant was added
to an 2,2'-azinobis-(3-ethylbenzthiazoline-6-sulfonate) radical
solution. The decrease in radical concentration was monitored
spectrophotometrically and related to the decrease obtained with
Trolox.
Serum vitamin A and E and carotenoid concentrations were quantified by
reversed phase HPLC using a modified version of a method described
previously (22)
. Tocopherols were quantified by
fluorometric detection, and vitamin A and carotenoid profiles were
quantified with diode array detection.
Vitamin C in deproteinized blood was analyzed by an HPLC method with
fluorometric detection (20)
. Vitamin C was oxidized to
dehydroascorbic acid and subsequently condensed with 1,2-diaminobenzene
to quinoxaline, which was detected.
Lipid, protein and DNA oxidative damage.
MDA was determined in plasma by derivatization of MDA with
thiobarbituric acid and quantified by HPLC separation with a
fluorometric detector according to a method described by Fukunaga et
al. (26)
. Plasma 8-epi-prostaglandin F2
was
measured according to a method described by Nourooz-Zadeh et al.
(27)
with some modifications. This method involves
solid-phase extraction and conversion to pentafluorobenzyl ester
and trimethylsilyl ether derivatives. 8-Epi-prostaglandin
F2
was quantified using negative-ion chemical
ionization high resolution mass spectrometry. Plasma protein carbonyl
content was quantified by the reaction with 2,4-dinitrophenylhydrazine,
as previously described by Buss et al. (28)
, using an
enzyme-linked immunosorbent assay.
DNA oxidative damage, measured as the Comet assay, was conducted as
described by Collins et al. (29)
. The DNA strand breaks
were analyzed in untreated, H2O2-treated (to
monitor resistance of the cells to oxidative stress) and endonuclease
IIItreated (to detect levels of oxidized pyrimidine bases) isolated
human PBMC. Comets were analyzed quantitatively (100 cells per samples)
using image analysis software (Comet Assay II; Perceptive Instruments,
Suffolk, U.K.). The tail moments were converted to visual scoring
system (Collins score) from class 0 (no damage) to class 4 (almost all
DNA in tail).
Markers of oxidative stress.
The GSH/GSSG ratio was determined in erythrocytes according to the
method described by Baker et al. (30)
using the enzymatic
DTNB-reductase recycling method. Reduced glutathione (GSH) is
oxidized by DTNB leading to the formation of oxidized glutathione
(GSSG) and TNB (5-thio-2-nitrobenzoic acid). The formation of TNB was
measured at 405 nm. GSSG was determined after derivatization of GSH
with 2-vinylpyridine.
GST-
enzyme activity in plasma was analyzed using the Biotrin
HEPKIT-Alpha kit (Biotrin International, Dublin, Ireland) for
quantitative determination of GST-
, and GST-
in PBMC was analyzed
using the Biotrin HEPKIT-Pi kit (Biotrin International) for
quantitative determination of GST-
.
NF-
B activity in PBMC was analyzed according to method described by
van den Berg et al. (31)
as a "functional" marker of
oxidative stress. The electromobility shift assay (EMSA) with phosphor
imaging was used to detect NF-
B. For the quantification of NF-
B
activity, a commercially obtained HeLa nuclear (protein) extract
(Promega Benelux, Leiden, The Netherlands) was used as a standard on
each gel. NF-
B activity was expressed as HeLa equivalents/10 µg
protein.
Statistical analysis
Data were analyzed using the SAS statistical software package (SAS/STAT Version 6; SAS Institute, Cary, NC). All data are expressed as means ± SD. Effects of consumption of the vegetable and fruit concentrates on variables measured were tested by analysis of variance using the General Linear Model procedure. Only the 22 subjects with results for both treatments were included in the analysis. Results are based on those 22, unless indicted otherwise in the tables. Differences were considered significant at 0.05.
| RESULTS |
|---|
|
|
|---|
The 22 men which entered the study were 33 ± 11 y old
(range, 1949 y), had a BMI of 23.6 ± 3.0
kg/m2 (range, 19.128.5
kg/m2) and smoked 18 ± 7 cigarettes/d
(range, 1040 cigarettes/d). The vegetable and fruit intake of the
men, as assessed by a food frequency questionnaire, was estimated to be
167 g/d, which is around the 50th percentile of the Dutch male
population (174 g/d) (32)
. The test products were well
tolerated by the subjects, and compliance to the study protocol was
good (>98% of all study products were used), as judged from the
reported product consumption and the return of the remaining products.
Subjects smoking habits were the same for both treatment periods, as
judged by the returned question forms. None of the subjects had to be
excluded due to illness.
Body weight, blood pressure, heart rate and serum lipid concentrations
were not affected by the treatments (Table 3
).
|
Antioxidant status.
Serum vitamin C level was significantly increased (P < 0.0001) after the VB/FD treatment compared with the CB/CD treatment
(Table 4
). Serum levels of
-carotene, ß-carotene, ß-cryptoxanthin and
zeaxanthin were also significantly higher (P < 0.0001)
after the VB/FD treatment, whereas serum lycopene and lutein levels did
not differ between treatment periods (Table 4)
. Plasma TEAC was
significantly increased after consumption of the VB and FD compared
with the control products (Table 4)
. Serum retinol and tocopherol
concentrations were not affected by the VB/FD treatment (Table 4)
.
|
|
and GST-
,
GSH, GSSG, the GSH/GSSG ratio and NF-
B activity (in PBMC) are
summarized in Table 6
activity did not differ between treatments, but GST-
activity was slightly, but significantly, lower at the end of the
vegetable treatment period compared with the end of the control
treatment (P = 0.048). Erythrocyte levels of GSH and
oxidized GSSG, respectively, the GSH/GSSG ratio, were not affected by
the type of treatment. The NF-
B activity, expressed as HeLa
equivalents/10 µg protein also was not affected by the type of
treatment.
|
| DISCUSSION |
|---|
|
|
|---|
The aim of this study was to evaluate the sensitivity of a number of biomarkers of oxidative damage and (functional) biomarkers of oxidative stress and to demonstrate beneficial effects with these biomarkers, in a potential risk group of smoking males with a relatively low habitual fruit and vegetable consumption, by increasing their intake of natural antioxidants and of other bioactive compounds from fruit and vegetables.
From the results as summarized in Tables 5
and 6
, it is, however, clear
that no effect on markers of oxidative lipid, protein, DNA damage and
functional markers of oxidative stress could be demonstrated after a
treatment period of 3 wk with these test products.
To account for these findings and apparent discrepancies with reported studies, the following items are discussed: i) the additional antioxidant dose achieved by the test products in relation to the anticipated response and ii) the study design, i.e., "suitability" of the study population and "power" of the study.
Antioxidant dose achieved by the test products in relation to the anticipated response (antioxidant status).
Analysis of the VB/FD, summarized in Table 2
, showed that these
products indeed contained substantial amounts of antioxidants and had a
high potential (TEAC). The high TEAC of the VB and the FD is largely
explained by the high vitamin C content (118 mg in the VB and 53 mg in
the FD) and the contribution from other natural antioxidants, such as
flavonoids. Consumption of these products did indeed result in an
increase in the serum levels of vitamin C,
-carotene, ß-carotene,
ß-cryptoxanthin and zeaxanthin, respectively, as well as in
an increased total plasma antioxidant capacity, measured as the TEAC
(Table 4)
. The main contribution to the product TEAC comes from vitamin
C and the flavonoids, whereas carotenoids do not, or only minimally,
contribute (24)
. The total flavonoid content measured in
the product was
28 mg for the VB and
57 mg in the FD, and
2030% of the TEAC might be explained by the flavonoids and other
bioactive compounds with antioxidant capacity present. An uncertain
factor is the bioavailability and postprandial metabolism of flavonoids
contained in the products. As far as data are available, it seems that
bioavailability of flavonoids is generally low (36)
.
Plasma flavonoid levels were not determined, but the increase in plasma
TEAC might be in part explained by these compounds (or metabolites).
The additional amount of vitamin E provided by the VB was
8.2 mg
-tocopherol equivalents (
-TE) and
3.0 mg
-TE for the CB.
According to Traber and Sies (37)
, a daily dietary intake
of
1530 mg
-tocopherol would be needed to reach an
"optimal" plasma
-tocopherol level above 30 µmol/L, associated
with lower cardiovascular and cancer risk. We have no data on the
actual total dietary vitamin E intake in our subjects, but serum
-tocopherol levels were slightly below 30 µmol/L. Observational
epidemiological and intervention studies indicate that the major effect
(if any) of vitamin E supply are found only with a daily intake higher
than 74 mg
-TE (34)
. Therefore, the amount used in the
present study apparently was not sufficient to increase the serum
tocopherol level and/or to affect parameters of oxidative damage and
stress.
The carotenoid content of the VB was at least 5070% lower as
expected from the contents in the equivalent "fresh" vegetables.
Lycopene content was 1.3 mg, whereas
3 mg was expected on the basis
of
47 g "fresh" tomatoes. For lutein, the expected content was
3 mg, but only 0.85 mg was detected. Apparently, losses have
occurred in production of the VB, which included blanching and
freeze-drying (35)
.
The lowest lycopene intake reported to increase plasma lycopene levels
is 3.3 mg in heat processed vegetable juice given for 15 d
(38)
. In other studies, using tomato products, higher
amounts were achieved, such as 40 mg/d (39)
, 16.5 mg/d
(40)
or 10 mg/d (41)
to increase plasma
lycopene levels. The bioavailability of lycopene, which depends on the
matrix, is also an important factor. Bohm and Bitsch (42)
reported that lycopene from capsules and tomato juice (processed
tomatoes) was better absorbed from the intestine than lycopene from raw
tomatoes. They also showed that administration of 5 mg lycopene/d did
not affect plasma antioxidant capacity. If the protective effect of
tomatoes on prostate cancer risk is indeed due to lycopene then the
protective lycopene intake should be
6.5 mg/d (17)
. In
the present study, the additional intake of lutein and lycopene from
the burger was apparently too low to achieve an increase of serum
levels.
The VB/FD provided per day an additional 4.0 mg
-carotene and 9.0 mg
ß-carotene. This resulted in an increase in plasma
- and
ß-carotene. ß-Cryptoxanthin and zeaxanthin levels were also
increased, but the obtained higher levels were not associated with
changes in oxidative stress and damage-related markers. Using data
reported in the various epidemiological trials on cardiovascular risk
and mainly observational studies, a threshold level for serum
ß-carotene of 0.4 µmol/L has been derived (43)
. This
level is reached at an intake of
1.52 mg ß-carotene/d. We have no
data on the actual total ß-carotene dietary intake in our subjects,
but ß-carotene levels were
0.3 µmol/L after CB/CD and 0.67
µmol/L after VB/FD treatment. "High dose" supplementation with
synthetic ß-carotene in smokers has been associated with an increased
risk for lung cancer (44
,45)
.
Previously, reduced genetic damage by natural products has been
reported in humans, using the Comet assay (39)
. After a
2-wk carotenoid depletion period, followed by a daily intake for 2 wk
of 330 mL tomato juice (containing 40 mg lycopene) or 330 mL carrot
juice (containing 22.3 mg
-carotene and 15.7 mg ß-carotene) or
10 g dried spinach powder (containing 11.3 mg lutein), a
significant decrease in endogenous levels of strand breaks in
lymphocyte DNA has been found.
Vitamin C is an important contributor to the oxidant defense system and
has been shown to protect against in vivo oxidation of lipids and DNA
in humans, particularly in persons exposed to enhanced oxidative
stress, such as smokers (33
,46)
. Numerous epidemiological
studies strongly suggest that 90100 mg vitamin C/d (33)
,
and plasma concentrations of >50 µmol/L (47)
have been
associated with a lower incidence and mortality from cardiovascular
disease and cancer.
The VB/FD provided an additional vitamin C intake of 170.5 mg/d. This
resulted in an increase in plasma vitamin C level of
20 µmol/L.
This increase likely explains the increase in plasma TEAC (+38
µmol/L). Calculated using the TEAC of 1 for vitamin C
(24)
, the contribution of vitamin C to the increase in
TEAC is
83%. However, for analysis of plasma TEAC, no precautions
could be taken to prevent loss of vitamin C, as done for analysis of
vitamin C, and therefore the contribution of vitamin C to the increase
in TEAC might be overestimated.
In our subjects, vitamin C levels were
40 µmol/L before and 58
µmol/L after VB/FD treatment. This is in line with kinetic data
showing an increase in fasting plasma levels of vitamin C to
60
µmol/L, after a 200-mg dose (48)
.
High dose supplementation with vitamin C (500 mg/d) has been shown to
elevate red blood cell glutathione in healthy adults (49)
.
Erythrocyte glutathione oxidation is considered to be a consistent
marker of oxidative stress (50)
.
In our study, the GSH/GSSG ratio was not altered, but GSH levels
appeared to be lower than baseline after both treatments.
Hininger et al. (41)
reported increased GSH levels in
smokers, which also decreased to the "normal" nonsmoking levels
after a fruit and vegetablerich diet. This increase was unrelated to
an increase in GSSG. The observed higher GSH in erythrocytes of smokers
might reflect an adaptation to enhanced production of reactive oxygen
species from cigarettes.
Duthie et al. (51)
reported that supplementation of the
diet for 20 wk with vitamin C (100 mg/d), in combination with vitamin E
(280 mg/d) and ß-carotene (25 mg/d), resulted in a highly significant
decrease in endogenous oxidative base damage in lymphocyte DNA of both
smokers and nonsmokers. In addition, lymphocytes of antioxidant
supplemented subjects showed an increased resistance to oxidative
damage when challenged in vitro with
H2O2.
Effect on (functional) markers of oxidative stress.
Antioxidant status and markers of oxidative damage (DNA adducts, lipid
and protein oxidation products) are frequently used to assess
antioxidant and pro-oxidant effects. However, gene expression,
being an important modulator of cell functions, has been shown, in some
cases, to be under redox control. Changes in gene expression can
provide a sensitive marker of oxidative stress (or changes in oxidative
status). A well-defined transcription factor, NF-
B, has been
identified to be regulated by the intracellular redox state. Activation
of the transcription factor NF-
B was measured in this study to
assess the potential of these markers as a functional marker of
oxidative stress. This redox-controlled mechanism is quite distinct
from the response to antioxidant that involves up-regulation of
certain specific genes (e.g., glutathione-S-transferase) as
a consequence, for example, of the antioxidant responsive element
present in the promotor. Such genes respond to a diverse selection of
antioxidants and might reflect changes in oxidative status. Induction
of both glutathione-S-transferases (GST-
and GST-
), a
family of phase II enzymes, was measured in this study to assess the
potential of these markers as markers of oxidative stress.
Induction of phase II enzymes has been postulated as a key mechanism
for the anticarcinogenic effects of fruits, vegetables and antioxidants
(52
53
54)
. GST are able to conjugate electrophiles with
glutathione or by a glutathione-dependent peroxidase activity. They
may also participate in the repair of cellular macromolecules damaged
by oxidative stress. In addition, GST-
can react directly with
reactive oxygen species via a sensitive SH-group or be inactivated
by disulfide formation that can be reversed by glutathione. Therefore,
it has a specific response to oxidative stress (55)
.
Several genetic elements in the promoter regions of the genes encoding
phase II enzymes have been identified. GST-
is regulated by the
redox status of the cell (55)
. In the regulatory element
of the GST-
gene, an antioxidant responsive element, as well as a
NF-
Bbinding site, has been identified.
In our study, GST-
was lower after treatment with the VB/FD compared
with the CB/CD. This is in contrast with a previous study with
nonsmokers, where an induction of GST-
was observed in 6 of the 23
subjects after treatment with tomato and carrot juices
(39)
. Smokers may have higher levels of GST-
compared
with nonsmokers to protect them against oxidative stress caused by
smoking. A higher intake of antioxidants prevents formation of reactive
oxygen species, and therefore GST-
is down-regulated.
NF-
B is activated by oxidative stress, and this enhanced activity
can be modulated by antioxidants (56)
. To assess in vivo
NF-
B activity, the activation was measured in freshly isolated PBMC.
In a previous study, we found a higher NF-
B activity in male
"heavy" smokers compared with nonsmokers (57)
. Because
of the high TEAC of the VB/FD, the relatively high concentrations of
vitamin C and quercetin, a decrease in NF-
B activation was
anticipated. In vitro reduction of NF-
B activation by antioxidants
has been reported, such as by vitamin C, vitamin E and resveratrol
(19
,58)
. However, we did not find a counteraction in the
present study.
Study design: "suitability" of the study population and test products, "power" of the study.
The study was designed as a randomized, free living, open,
placebo-controlled, cross-over study to simulate the normal home
situation and intervention with processed vegetables, rather than with
food supplements. Compliance was checked and considered adequate.
Subjects supplemented the product to their usual diet. However, no
further data on the actual fruit and vegetable intake during the study
were collected. Replacement of other food products and changes in
dietary pattern as a result of the intervention per se therefore cannot
be excluded but, if any, should be balanced by the cross-over
design with isoenergetic placebo products. Also, the selection of male
smokers with a relatively low fruit and vegetable intake on the basis
of food questionnaires might have been insufficiently discriminative to
select subjects with increased oxidative stress. In some studies, e.g.,
Bub et al. (59)
, a depletion stage was included in which
subjects are fed a "low carotenoid diet" before the actual
intervention, which might increase the sensitivity and power of the
design to demonstrate effects.
Smokers are considered to be exposed to an increased oxidative stress,
because of their apparent lower antioxidant intake (60)
in
combination with a relatively high free radical exposure. Several
studies have been reported showing lower antioxidant vitamin and/or
carotenoid plasma levels in smokers (41
,61
,62)
. This also
is true with respect to markers of oxidative damage, such as increased
plasma conjugated dienes (63)
, increased oxidative DNA
damage (51)
or increased plasma levels of
F2-isoprostanes (64)
.
We recently reported that (baseline) NF-
B activity is higher in male
smokers compared with nonsmokers (57)
. However, we did not
compare the present baseline data with those for a comparable group of
nonsmokers. Comparison with values reported by other groups is
complicated because of methodological differences and, for some
markers, relatively large interassay variabilities.
Test products.
To maximize the intake of natural antioxidants, we used a VB and an FD, prepared from commercially obtained ingredients (freeze-dried vegetables and fruit extracts), selected because of their potential antioxidant contents and reported health effects. These VB/FD had indeed relatively "high" TEAC, but for some compounds, such as the carotenoids, the actual additional intake achieved was lower than anticipated, most probably because of losses during processing of the extracts/lyophilized products. As discussed above, carotenoid and vitamin E levels were apparently too low to achieve an effect, if any, on the markers evaluated in this study.
Power of the study.
The relatively low antioxidant content of the test products and/or the
low level of oxidative stress in the study population may explain the
lack of effects of fruits and vegetables supplementation on the
selected biomarkers in our study. To assess the sensitivity of these
markers, we used our data set to calculate the number of subjects
needed to demonstrate a 10% difference between treatments (
= 0.05, two-sided and a power of 80%). Based on the observed
within-subject variability during treatment with the control
products, we calculated that for some of the biomarkers, the number of
subjects was indeed insufficient. Table 7
shows that in our study, using 22 subjects, only an effect (10%
difference) on protein carbonyls and plasma TEAC could have been
demonstrated.
|
| FOOTNOTES |
|---|
B, nuclear transcription factor-
B; PBMC, peripheral blood mononuclear cells; TEAC, trolox equivalent antioxidant capacity; VB, vegetable burger. Manuscript received January 2, 2001. Initial review completed January 25, 2001. Revision accepted March 12, 2001.
| REFERENCES |
|---|
|
|
|---|
1. Block G., Patterson B., Subar A. Fruit, vegetables and cancer prevention: a review of the epidemiological evidence. Nutr. Cancer 1992;18:1-29[Medline]
2.
Bresnick E., Birt D. F., Wolterman K., Wheeler M., Markin R. S. Reduction in mammary tumorigenesis in the rat by cabbage and cabbage residue. Carcinogenesis 1990;11:1159-1163
3.
Wattenberg L. W., Coccia J. B. Inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone carcinogenesis in mice by D-limonene and citrus fruit oils. Carcinogenesis 1991;12:115-117
4.
Mahmoud N. N., Carothers A. M., Grunberger D., Bilinski R. T., Churchill M. R., Martucci C., Newmark H. L., Bertagnolli M. M. Plant phenolics decrease intestinal tumors in an animal model of familial adenomatous polyposis. Carcinogenesis 2000;21:921-927
5.
Rimm E. B., Katan M. B., Ascherio A., Stampfer M. J., Willett W. C. Relation between intake of flavonoids and risk for coronary heart disease in male health professionals. Ann. Intern. Med. 1996;125:384-389
6. Gillman M. W., Cupples L. A., Gagnon D., Posner B. M., Ellison R. C., Castelli W. P., Wolf P. A. Protective effect of fruits and vegetables on development of stroke in men. J. Am. Med. Assoc. 1995;273:1113-1117[Abstract]
7. Benzie I. F. Lipid peroxidation: a review of causes, consequences, measurement and dietary influences. Int. J. Food Sci. Nutr. 1996;47:233-261[Medline]
8. Halliwell B. Oxidative stress, nutrition and health: experimental strategies for optimization of nutritional antioxidant intake in humans. Free Radic. Res. 1996;25:57-74[Medline]
9. Pool-Zobel B. L., Bub A., Liegibel U. M., Treptow-van Lishaut S., Rechkemmer G. Mechanisms by which vegetable consumption reduces genetic damage in humans. Cancer Epidemiol. Biomarkers Prev. 1997;7:891-899[Abstract]
10.
Porrini M., Riso P. Lymphocyte lycopene concentration and DNA protection from oxidative damage is increased in women after a short period of tomato consumption. J. Nutr. 2000;130:189-192
11.
Young J. F., Nielsen S. E., Haraldsdottir J., Daneshvar B., Lauridsen S. T., Knuthsen P., Crozier A., Sandstrom B., Dragsted L. O. Effect of fruit juice intake on urinary quercetin excretion and biomarkers of antioxidative status. Am. J. Clin. Nutr. 1999;69:87-94
12.
Verhagen H., Poulsen H. E., Loft S., van Poppel G., Willems M. I., van Bladeren P. J. Reduction of oxidative DNA-damage in humans by Brussels sprouts. Carcinogenesis 1995;16:969-970
13. Van Poppel G., van den Berg H. Vitamins and cancer. Cancer Lett 1997;114:195-202[Medline]
14. Loft S., Poulsen H. E. Cancer risk and oxidative DNA damage in man. J. Mol. Med. 1996;74:297-312[Medline]
15. Baynes J. W., Thorpe S. R. Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes 1999;48:1-9[Abstract]
16.
Hertog M. G., Bueno de Mesquita H. B., Fehily A. M., Sweetnam P. M., Elwood P. C., Kromhout D. Fruit and vegetable consumption and cancer mortality in the Caerphilly Study. Cancer Epidemiol. Biomarkers Prev. 1996;5:673-677
17.
Giovanucci E. Tomatoes, tomato-based products, lycopene and cancer: review of the epidemiological literature. J. Natl. Cancer Inst. 1999;91:317-331
18.
Broekmans W.M.R., Klopping-Ketelaars I.A.A., Schuurman C.R.W.C., Verhagen H., van den Berg H., Kok F. J., van Poppel G. Fruits and vegetables increase plasma carotenoids and vitamins and decrease homocysteine in humans. J. Nutr. 2000;130:1578-1583
19. Sen C. K., Packer L. Antioxidant and redox regulation of gene transcription. FASEB J 1996;10:709-720[Abstract]
20. Speek A. J., Schrijver J., Schreurs W.H.P. Fluorimetric determination of total vitamin C and total vitamin iso-C in foodstuff and beverages by high performance liquid chromatography with pre-column derivatization. J. Agr. Food Chem. 1984;32:352-355
21. Speek A. J., Schrijver J., Schreurs W.H.P. The vitamin E composition of some seed oils as determined by high performance liquid chromatography with fluorometric detection. J. Food Sci. 1985;50:121-124
22. Van Vliet T., van Schaik F., van Schoonhoven J., Schrijver J. Determination of several retinoids, carotenoids and E vitamers by high-performance liquid chromatography: application to plasma and tissues of rats fed a diet rich in either beta-carotene or canthaxanthin. J. Chromatogr. 1991;553:179-186[Medline]
23. Hertog M. G., Hollman P. C., Venema D. P. Optimization of a quantitative HPLC determination of potentially anticarcinogenic flavonoids in vegetable and fruits. J. Agric. Food. Chem. 1992;40:1591-1598
24. Van den Berg R., Haenen G.R.M.M., van den Berg H., Bast A. Applicability of an improved Trolox equivalent antioxidant capacity (TEAC) assay for evaluation of antioxidant capacity measurements of mixtures. Food Chem 1999;66:511-517
25. Friedewald W. T., Levy R. I., Fredrickson D. S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 1972;18:499-502[Abstract]
26. Fukunaga K., Yoshida M., Nakazono N. A simple, rapid, highly sensitive and reproducible quantification method for plasma malondialdehyde by high-performance liquid chromatography. Biomed. Chromatogr 1998;12:300-303[Medline]
27. Nourooz-Zadeh J., Gopaul N. K., Barrow S., Mallet A. I., Anggard E. E. Analysis of F2-isoprostanes as indicators of non-enzymatic lipid peroxidation in vivo by gas chromatography-mass spectrometry: development of a solid-phase extraction procedure. J. Chromatogr. B. Biomed. Appl. 1995;667:199-208[Medline]
28. Buss H., Chan T. P., Sluis K. B., Domigan N. M., Winterbourn C. C. Protein carbonyl measurement by a sensitive ELISA method. Free Radic. Biol. Med. 1997;23:361-366[Medline]
29.
Collins A. R., Duthie S. J., Dobson V. L. Direct enzymic detection of endogenous oxidative base damage in human lymphocyte DNA. Carcinogenesis 1993;14:1733-1735
30. Baker M. A., Cernigilia G. J., Aman A. Microtiterplate assay for the measurement of glutathione and glutathione disulphide in large number of biological samples. Anal. Biochem. 1990;190:360-365[Medline]
31.
Van den Berg, R., Haenen, G.R.M.M., van den Berg, H. & Bast, A. (2001) Nuclear factor-
B as a potential biomarker of oxidative stress. Br. J. Nutr. (in press).
32. Hulshof K.F.A.M., Kistenmaker C., Bouwmans M., Löwik M.R.H. Energy and nutrient intake of the Dutch populationDutch Nutrition Surveillance System 19971998 1998:1-13TNO report V98.805 (in Dutch)
33.
Carr A. C., Frei B. Towards a new recommended dietary allowance for vitamin C based on antioxidant and health effect in humans. Am. J. Clin. Nutr. 1999;69:1086-1107
34. Bramley P. M., Elmadfa I., Kafatos A., Kelly F. J., Manios Y., Roxborough H. E., Schuch W., Sheehy P.J.A., Wagner K-H. Vitamin E. J. Sci. Food Agric. 2000;80:913-938
35. Van den Berg H., Faulks R., Fernando-Granado H., Hirschberg J., Olmedilla B., Sandman G., Southon S., Stahl W. The potential for the improvement of carotenoid levels in food and the likely systemic effects. J. Sci. Food Agric. 2000;80:880-912
36. Hollman P. C. Bioavailability of flavonoids. Eur. J. Clin. Nutr. 1997;51:S66-S69
37. Traber, M. G. & Sies, H. (1996) Vitamin E in humans: demand and delivery. In: Annual Reviews in Nutrition (McCormick, D. B., ed.), pp. 321347, Vol 16, Annual Reviews, Palo Alto, CA.
38.
Yeum K. J., Booth S. L., Sadowski J. A., Liu C., Tang G., Krinsky N. I., Russell R. M. Human plasma carotenoid response to the ingestion of controlled diets high in fruits and vegetables. Am. J. Clin. Nutr. 1996;64:594-602
39.
Pool-Zobel B. L., Bub A., Müller H., Wollowski I., Rechkemmer G. Consumption of vegetables reduces genetic damage in humans: first results of an intervention trial with carotenoid-rich foods. Carcinogenesis 1997;18:1847-1850
40.
Riso P., Pinder A., Santangelo A., Porrini M. Does tomato consumption effectively increase the resistance of lymphocyte DNA to oxidative damage?. Am. J. Clin. Nutr 1999;69:712-718
41. Hininger I., Chopra M., Thurnham D. I., Laporte F., Richard M. J., Favier A., Roussel A. M. Effect of increased fruit and vegetable intake on the susceptibility of lipoprotein to oxidation in smokers. Eur. J. Clin. Nutr. 1997;51:601-606[Medline]
42. Bohm V., Bitsch R. Intestinal absorption of lycopene from different matrices and interactions to other carotenoids, the lipid status, and the antioxidant capacity of human plasma Eur. J. Nutr. 1999;38:118-125
43. Gey K. F. Ten-year retrospective on the antioxidant hypothesis of arteriosclerosis: threshold plasma levels of antioxidant micronutrients related to minimum cardiovascular disease. Nutr. Biochem. 1995;6:206-236
44. ATBC Study Group (the Alpha-Tocopherol, ß-Carotene Cancer Prevention Study Group) The effects of vitamin E and ß-carotene on the incidence of lung cancer and other cancers in male smokers. N. Engl. J. Med. 1994;334:1019-1035
45.
Omenn G. S., Goodman G. E., Thornquist M. D., Balmes J., Cullen M. R., Glass A., Keogh J. P., Meyskens F. L., Jr, Valanis B., Williams J. H., Jr, Barnhart S., Cherniack M. G., Brodkin C. A., Hammar S. Risk factors for lung cancer and for intervention effects in CARET, the Beta-Carotene and Retinol Efficacy Trial. J. Natl. Cancer Inst. 1996;88:1550-1559
46. Henning S. M., Zhang J. Z., McKee R. W., Swendseid M. E., Jacob R. A. Glutathione blood levels and other oxidant defense indices in men fed diets low in vitamin C. J. Nutr. 1991;121:1969-1975
47. Gey K. F. Vitamins E plus C and interacting conutrients required for optimal health: a critical and constructive review of epidemiology and supplementation data regarding cardiovascular disease and cancer. Biofactors 1998;7:113-174[Medline]
48. Levine M., Rumsey S. C., Wang Y., Park J., Kwon O., Amano N. In situ kinetics: an approach to recommended intake of vitamin C. Methods Enzymol 1997;281:425-437[Medline]
49.
Johnston C. S., Meyer C. G., Srilakshmi J. C. Vitamin C elevates red blood cell glutathione in healthy adults. Am. J. Clin. Nutr. 1993;58:103-105
50. Exner R., Wessner B., Manhart N., Roth E. Therapeutic potential of glutathione. Wien. Klin. Wochenschr. 2000;112:610-616[Medline]
51.
Duthie S. J., Ma A., Ross M. A., Collins A. R. Antioxidant supplementation decreases oxidative DNA damage in human lymphocytes. Cancer Res 1996;56:1291-1295
52.
Bogaards J. J., Verhagen H., Willems M. I., Van Poppel G., van Bladeren P. J. Consumption of Brussels sprouts results in
-class glutathione S-transferase levels in human blood plasma. Carcinogenesis 1994;15:1073-1075
53. Hayes J. D., Pulford D. J. The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit. Rev. Biochem. Mol. Biol. 1995;30:445-600[Medline]
54.
Nijhoff W. A., Mulder T. P., Verhagen H., van Poppel G., Peters W. H. Effects of consumption of Brussels sprouts on plasma and urinary glutathione S-transferase class-alpha and -pi in humans. Carcinogenesis 1995;16:955-957
55. Xia C., Hu J., Ketterer B., Taylor J. B. The organization of the human GSTP11 gene promoter and its response to retinoic acid and cellular redox status. Biochem. J. 1996;313:155-161
56.
Blackwell T. S., Blackwell T. R., Holden E. P., Christman B. W., Christman J. W. In vivo antioxidant treatment suppresses nuclear factor-
B activation and neutrophillic lung inflammation. J. Immunol. 1996;157:1630-1637[Abstract]
57.
Van den Berg R., Haenen G.R.M.M., Van den Berg H., Bast A. Nuclear factor-
B activation is higher in peripheral blood mononuclear cells of male smokers. Environ. Toxicol. Pharmacol. 2001;9:147-151[Medline]
58.
Manna S. K., Mukhopadhyay A., Aggarwal B. B. Resveratrol suppresses TNF-induced activation of nuclear transcription factors NF-kappa B, activator protein-1, and apoptosis: potential role of reactive oxygen intermediates and lipid peroxidation. J. Immunol. 2000;164:6509-6519
59. Bub A., Watzl B., Abrahamse L., Delincee H., Adam S., Wever J., Muller H., Rechkemmer G. Moderate intervention with carotenoid-rich vegetable products reduces lipid peroxidation in men J. Nutr 2000;130:2200-2206
60. Marangon K., Herbeth B., Lecomte E., Paul-Dauphin A., Grolier P., Chancerelle Y., Artur Y., Siest G. Diet, antioxidant status, and smoking habits in French men. Am. J. Clin. Nutr. 1998;67:231-239[Abstract]
61.
Stryker W. S., Kaplan L. A., Stein E. A., Stampfer M. J., Sober A., Willett W. C. The relation of diet, cigarette smoking, and alcohol consumption to plasma beta-carotene and alpha-tocopherol levels. Am. J. Epidemiol. 1988;127:283-296
62. Weber P., Bendich A., Schalch W. Vitamin C and human healtha review of recent data relevant to human requirements. Int. J. Vitam. Nutr. Res. 1996;66:19-30[Medline]
63.
Duthie G. G., Arthur J. R., James W. P. Effects of smoking and vitamin E on blood antioxidant status. Am. J. Clin. Nutr. 1991;53:1061S-1063S
64.
Morrow J. D., Frei B., Longmire A. W., Gaziano J. M., Lynch S. M., Shyr Y., Strauss W. E., Oates J. A., Roberts L. J., II Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers: smoking as a cause of oxidative damage. N. Engl. J. Med. 1995;332:1198-1203
This article has been cited by other articles:
![]() |
J. P. Mills, P. W. Simon, and S. A. Tanumihardjo Biofortified Carrot Intake Enhances Liver Antioxidant Capacity and Vitamin A Status in Mongolian Gerbils J. Nutr., September 1, 2008; 138(9): 1692 - 1698. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Thomson, N. R. Stendell-Hollis, C. L. Rock, E. C. Cussler, S. W. Flatt, and J. P. Pierce Plasma and Dietary Carotenoids Are Associated with Reduced Oxidative Stress in Women Previously Treated for Breast Cancer Cancer Epidemiol. Biomarkers Prev., October 1, 2007; 16(10): 2008 - 2015. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Fowke, J. D. Morrow, S. Motley, R. M. Bostick, and R. M. Ness Brassica vegetable consumption reduces urinary F2-isoprostane levels independent of micronutrient intake Carcinogenesis, October 1, 2006; 27(10): 2096 - 2102. [Abstract] [Full Text] [PDF] |
||||
![]() |
|